Cargando…

The anti-ferroptotic role of FSP1: current molecular mechanism and therapeutic approach

Detalles Bibliográficos
Autores principales:	Zeng, Furong, Chen, Xiang, Deng, Guangtong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Nature Singapore 2022
Materias:	Research Highlight
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9708954/ https://www.ncbi.nlm.nih.gov/pubmed/36445538 http://dx.doi.org/10.1186/s43556-022-00105-z

Ejemplares similares

Tumor neutrophils ferroptosis: a targetable immunosuppressive mechanism for cancer immunotherapy
por: Du, Songtao, et al.
Publicado: (2023)

DHODH tangoing with GPX4 on the ferroptotic stage
por: Wang, Fudi, et al.
Publicado: (2021)

Disulfidptosis: a new form of regulated cell death for cancer treatment
por: Meng, Yu, et al.
Publicado: (2023)

TRPV1 as an anti-ferroptotic target in osteoarthritis
por: Riegger, Jana
Publicado: (2022)

Molecular characterization of AIFM2/FSP1 inhibition by iFSP1-like molecules
por: Xavier da Silva, Thamara Nishida, et al.
Publicado: (2023)

Regulatory T cells as a therapeutic approach for inflammatory bowel disease
por: Laukova, Marcela, et al.
Publicado: (2023)

The influenza chronicles: From the 1918 pandemic to current understanding of host defense mechanisms
por: Louise Walton, Emma
Publicado: (2018)

Mechanical nanosurgery approach: assistance to overcome the chemotherapy resistance of glioblastoma
por: Chen, Qi, et al.
Publicado: (2023)

Organoid-based chemical approach to dissect the mechanism controlling cellular dynamics
por: Lacko, Lauretta A, et al.
Publicado: (2019)

Single cell RNA-seq analysis identifies ferroptotic chondrocyte cluster and reveals TRPV1 as an anti-ferroptotic target in osteoarthritis
por: Lv, Zhongyang, et al.
Publicado: (2022)

Targeting B cells and plasma cells in autoimmune diseases: From established treatments to novel therapeutic approaches
por: Merino‐Vico, Ana, et al.
Publicado: (2022)

Anti-ferroptotic mechanism of IL4i1-mediated amino acid metabolism
por: Zeitler, Leonie, et al.
Publicado: (2021)

Targeting programmed death ligand 2/repulsive guidance molecule b pathway: a novel strategy to subdue tumor immunotherapy resistance to anti‐programmed death 1/programmed death ligand 1
por: Xiang, Yuancai, et al.
Publicado: (2023)

FSP meeting at Siegen
Publicado: (2017)

Receptor-Independent Anti-Ferroptotic Activity of TrkB Modulators
por: Jakaria, Md., et al.
Publicado: (2022)

Anti-Ferroptotic Effects of Nrf2: Beyond the Antioxidant Response
por: Shakya, Aryatara, et al.
Publicado: (2023)

Fumarate hydratase inhibition activates innate immunity via mitochondrial nucleic acid release
por: Li, Xiang, et al.
Publicado: (2023)

Molecular fingerprinting catches responders to therapeutic agents
por: Malik, Simeen, et al.
Publicado: (2013)

Convalescent plasma for patients with COVID-19
por: Zeng, Furong, et al.
Publicado: (2020)

On the Mechanism of Cytoprotection by Ferrostatin-1 and Liproxstatin-1 and the Role of Lipid Peroxidation in Ferroptotic Cell Death
por: Zilka, Omkar, et al.
Publicado: (2017)

Innate immune signaling and immunothrombosis: New insights and therapeutic opportunities
por: Ryan, Tristram A. J., et al.
Publicado: (2022)

Unveiling new anti-inflammatory mechanisms of nanomaterials
por: Gu, Zhen
Publicado: (2023)

WNK1, a molecular crowding sensor, links phase separation to cellular physiological stress
por: Lan, Tinghui, et al.
Publicado: (2023)

Prostaglandin regulation of type 2 inflammation: From basic biology to therapeutic interventions
por: Oyesola, Oyebola O., et al.
Publicado: (2021)

Reversible mechanical control of molecular conformation
por: Bissette, Andrew J.
Publicado: (2020)

Multifunctional Nanomaterials for Ferroptotic Cancer Therapy
por: Shi, Zhiyuan, et al.
Publicado: (2022)

Mechanism of action of PD‐1 receptor/ligand targeted cancer immunotherapy [Image: see text]
por: Borst, Jannie, et al.
Publicado: (2021)

In search for novel strategies towards neuroprotection and neuroregeneration: is PPARα a promising therapeutic target?
por: Moreno, Sandra, et al.
Publicado: (2015)

The putative mechanism of lymphopenia in COVID-19 patients
por: Wang, Xinling, et al.
Publicado: (2022)

Janus kinase signaling as risk factor and therapeutic target for severe SARS‐CoV‐2 infection
por: Solimani, Farzan, et al.
Publicado: (2021)

Therapeutic silencing of FSP27 reduces the progression of atherosclerosis in Ldlr(−/−) mice
por: Rajamoorthi, Ananthi, et al.
Publicado: (2018)

How will previous infection or current vaccination strategies protect us from future SARS‐CoV‐2 variant infections?
por: Monteiro, Olivia
Publicado: (2022)

Gasdermin: a novel therapeutic target for tumour treatment by activating anti-tumour immunity
por: Fu, Caiyun
Publicado: (2020)

Induction of membraneless organelles as a strategy for HIV-1 post-nuclear entry steps
por: Zhou, Sheng, et al.
Publicado: (2023)

C‐type lectin receptors of the Dectin‐1 cluster: Physiological roles and involvement in disease
por: Tone, Kazuya, et al.
Publicado: (2019)

Fighting the enemy: one health approach against microbial resistance
por: Udaondo, Zulema, et al.
Publicado: (2020)

Tools of the trade: plasmid repositories and standardized plasmid manipulation for molecular and synthetic biology
por: Dolan, Stephen K., et al.
Publicado: (2022)

Toward a molecular understanding of fluoride stress in a model Pseudomonas strain
por: Wackett, Lawrence P.
Publicado: (2022)

Biochemical mechanism of erastin-induced ferroptotic cell death in neuronal cells: Role of PDI in ferroptosis
por: Hou, Ming-Jie, et al.
Publicado: (2023)

Adenovirus vector and mRNA vaccines: Mechanisms regulating their immunogenicity
por: Provine, Nicholas M., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_dj2u3cs9bc7muuae9o4u58hu7g